Venus Concept Inc Market Cap ($498.99K)
Market Cap & Net Worth: Venus Concept Inc (VERO)
Venus Concept Inc market cap. Venus Concept Inc (NASDAQ:VERO) has a market capitalization of $498.99K ($498.99K) as of November 5, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #31065 globally and #6307 in its home market, demonstrating a -12.60% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Venus Concept Inc's stock price $0.27 by its total outstanding shares 1859123 (1.86 Million). Also see Venus Concept Inc cash conversion from operations for how efficiently the company converts equity into cash flow.
Venus Concept Inc Market Cap History (2017–2026)
Venus Concept Inc market cap history from 2017 to 2026. Data shows change from $1.92 Billion to $498.99K (-65.47% CAGR). Check Venus Concept Inc (VERO) share price today for real-time trading data and today's change.
Index Memberships
Venus Concept Inc is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Health Care
IXHC
|
$2.61 Trillion | 0.00% | #911 of 976 |
|
NASDAQ Composite
IXIC
|
$40.20 Trillion | 0.00% | #2876 of 3165 |
Weight: Venus Concept Inc's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Venus Concept Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Venus Concept Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore VERO shareholders equity momentum to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
0.01x
Venus Concept Inc's market cap is 0.01 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2017 | $1.92 Billion | $21.30 Million | -$17.84 Million | 90.35x | N/A |
| 2018 | $182.21 Million | $21.96 Million | -$28.73 Million | 8.30x | N/A |
| 2019 | $131.07 Million | $110.41 Million | -$42.30 Million | 1.19x | N/A |
| 2020 | $48.24 Million | $78.01 Million | -$82.82 Million | 0.62x | N/A |
| 2021 | $47.41 Million | $105.62 Million | -$22.14 Million | 0.45x | N/A |
| 2022 | $8.92 Million | $99.50 Million | -$43.70 Million | 0.09x | N/A |
| 2023 | $2.19 Million | $76.35 Million | -$37.25 Million | 0.03x | N/A |
| 2024 | $699.96K | $64.83 Million | -$47.00 Million | 0.01x | N/A |
Competitor Companies of VERO by Market Capitalization
Companies near Venus Concept Inc in the global market cap rankings as of November 5, 2026. Also see Venus Concept Inc balance sheet assets for a full breakdown of the balance sheet.
Key companies related to Venus Concept Inc by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #110 globally with a market cap of $190.23 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #204 globally with a market cap of $119.12 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #226 globally with a market cap of $109.30 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #239 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #110 | Abbott Laboratories | NYSE:ABT | $190.23 Billion | $109.40 |
| #204 | Stryker Corporation | NYSE:SYK | $119.12 Billion | $310.55 |
| #226 | Medtronic PLC | NYSE:MDT | $109.30 Billion | $98.88 |
| #239 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
Market Capitalization of Venus Concept Inc (2017–2026)
Market capitalization of Venus Concept Inc from 2017 to today. Between 2017 and today, Venus Concept Inc's market cap moved from $1.92 Billion to $ 498.99K, with a yearly change of -65.47%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $498.99K | -81.86% |
| 2025 | $2.75 Million | +293.09% |
| 2024 | $699.96K | -68.09% |
| 2023 | $2.19 Million | -75.42% |
| 2022 | $8.92 Million | -81.18% |
| 2021 | $47.41 Million | -1.73% |
| 2020 | $48.24 Million | -63.19% |
| 2019 | $131.07 Million | -28.07% |
| 2018 | $182.21 Million | -90.53% |
| 2017 | $1.92 Billion | -- |
End of Day Market Cap According to Different Sources
On Nov 4th, 2026 the market cap of Venus Concept Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $498.99K USD |
| MoneyControl | $498.99K USD |
| MarketWatch | $498.99K USD |
| marketcap.company | $498.99K USD |
| Reuters | $498.99K USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Venus Concept Inc
Venus Concept Inc., a medical technology company, develops, commercializes, and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies, and related services in the United States and internationally. Its product portfolio includes Venus Legacy, a noninvasive device used in dermatological and general surgical procedures for females; Venus Versa, a multi-app… Read more